FERMT2 and colorectal carcinoma: Thus, our study directly addresses several unresolved clinical questions by uncovering a major latent variable affecting CRC prognosis, delineating the pro-tumorigenic role of myofibroblasts, and elucidating the functional contribution of FERMT2 and TNS1 to disease progression.